Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The primary objective is to explore in non-inferior efficacy of Myfortic administered at a dose of 2160mg/day in combination with reduced corticosteroid regimen compared to the combination with a standard corticosteroid regimen where efficacy measure is defined as the proportion of patients in complete remission after 24 weeks of treatment
Critère d'inclusion
- Systemic Lupus Nephritis